| Factor Information | |
|---|---|
| Data ID | 774 |
| Factor | NT-proBNP |
| Description | N/A |
| Biomarker | YES |
| Classification | E2 (physiological factor - biochemical index) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | children with PAH-CHD |
| p Value | <0.01 |
| Conclusion | Elevated plasma GDF-15 levels were positively related to NT-proBNP. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 482 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | CHD with LTRS/PDA/ASD/VSD, PDA/VSD/DORV/AVSD |
| Reference | |
|---|---|
| PMID | 28819713 |
| Year | 2017 |
| Title | Plasma Growth Differentiation Factor-15 is a Potential Biomarker for Pediatric Pulmonary Arterial Hypertension Associated with Congenital Heart Disease |
| Sample | ||
|---|---|---|
| Population | children | |
| Source | data | |
| Region | China,Sichuan | |
| Method | Spearman’s correlation analysis | |
| Race | Asian | |
| Disease History | N/A | |
| Treatment History | N/A | |
| Group | PAH-CHD(Treatment) | without PAH-CHD(Control) |
| Number | 46 | 39 |
| Age | 57±27.9 months(PAH-CHD) | 53 ± 33.7months(without PAH-CHD) |
| Gender (Male: Female) | 18:28(PAH-CHD) | 14:25(without PAH-CHD) |
| Marker Level | 376 (255–539) ng/L | 111 (47.7–168) ng/L |
